According to the Merriam-Webster Dictionary, the word “unliquidated” is defined as “not calculated or established as a specific amount.” The Post Holdings case (Post Holdings, Inc., and Michael Foods of Delaware, Inc., v. NPE Seller Rep LLC, C.A. No. 2017-0772 AGB [Del. Ch. Oct. 29, 2018]) Continue Reading
Rural Utilities Service Begins FY19 Broadband Loan Program, Revises Loan Limits
The Rural Utilities Service (RUS) announced on November 15, 2018, that it is now accepting fiscal year 2019 (FY19) applications for the Rural Broadband Access Loans and Loan Guarantees Program on a rolling first-come, first-served basis throughout FY19. RUS will rank submitted applications every 90 Continue Reading
IRS Announces Retirement Plan Limits for 2019
The Internal Revenue Service recently announced retirement contribution limits for 2019 adjusted for cost-of-living considerations. Below is a chart of the 2019 calendar year limits, together with those from 2018. General Plan Limits Annual Limit per Individual 2018 2019 Elective deferrals Continue Reading
IRS Issues Highly-Anticipated Guidance on Qualified Opportunity Zones
Significant tax incentives for investments by “qualified opportunity funds” in low-income communities designated as “qualified opportunity zones” were signed into law as part of the December 2017 legislation commonly known as the Tax Cuts and Jobs Act. Many investors have been hesitant to take Continue Reading
Venture Capital & Emerging Growth Companies Activities—November 2018
McCarter’s Venture Capital & Emerging Growth Companies Practice empowers clients throughout the development cycle—from ideation to creation, capitalization, implementation, commercialization and monetization. We are proud of the great things our clients are doing and are pleased to Continue Reading
Notice Poster for New Jersey’s Earned Sick Leave Law Released by Department of Labor for Use Starting on October 29
The New Jersey Department of Labor and Workforce Development (“NJDOL”) has released its notice poster pursuant to the Earned Sick Leave Law, N.J.S.A. 34:11D-1 et seq. (the “Law”), that takes effect on October 29, 2018. This notice, which is available in English and multiple other languages, has to Continue Reading
NJ Supreme Court Issues Another Landmark Decision in In re Accutane, this Time Regarding Choice-of-Law and the Presumption of Adequacy for FDA-Approved Warnings
Nearly two months to the day after the New Jersey Supreme Court issued a landmark decision in the In re Accutane® Litigation incorporating the Daubert factors into New Jersey law, the court issued another major decision in the same litigation that left no doubt about the strength of the presumption Continue Reading
Increased Transparency to Continuing Disclosure Requirements
In an effort to increase transparency and protect holders of municipal securities, on August 20, 2018, the US Securities and Exchange Commission (the “SEC” or the “Commission”) added two new requirements to the continuing disclosure requirements of Rule 15c2-12 of the Securities Exchange Act (the Continue Reading
McCarter Plays Key Role in New Jersey Supreme Court’s Landmark In re: Accutane Decision Regarding Expert Admissibility Standards
Until now, the perception that New Jersey law on expert admissibility was weaker than the Daubert standard used in federal courts and many other states—combined with New Jersey being home to so many pharmaceutical and medical technology companies—made New Jersey a magnet for mass tort litigation Continue Reading
New Jersey Biotechnology Task Force Recommends Angel Investor Tax Credit Program Expansion
Good news for investors and entrepreneurs: The New Jersey Biotechnology Task Force (Task Force)[1] has published its final report and recommendations to expand the Angel Investor Tax Credit Program with the goal of incentivizing companies in the life sciences industry to either remain in or relocate Continue Reading